DD100631A1 - - Google Patents

Info

Publication number
DD100631A1
DD100631A1 DD166641A DD16664172A DD100631A1 DD 100631 A1 DD100631 A1 DD 100631A1 DD 166641 A DD166641 A DD 166641A DD 16664172 A DD16664172 A DD 16664172A DD 100631 A1 DD100631 A1 DD 100631A1
Authority
DD
German Democratic Republic
Application number
DD166641A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD100631A1 publication Critical patent/DD100631A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DD166641A 1971-11-08 1972-11-02 DD100631A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI1185A HU165181B (en:Method) 1971-11-08 1971-11-08

Publications (1)

Publication Number Publication Date
DD100631A1 true DD100631A1 (en:Method) 1973-10-05

Family

ID=10994422

Family Applications (1)

Application Number Title Priority Date Filing Date
DD166641A DD100631A1 (en:Method) 1971-11-08 1972-11-02

Country Status (9)

Country Link
AT (1) AT332531B (en:Method)
CA (1) CA978479A (en:Method)
CS (1) CS217603B1 (en:Method)
DD (1) DD100631A1 (en:Method)
DE (1) DE2252665A1 (en:Method)
GB (1) GB1403900A (en:Method)
HU (1) HU165181B (en:Method)
IL (1) IL40685A (en:Method)
SU (1) SU1009467A1 (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2826642C2 (de) 1978-06-19 1987-04-23 Dr. Madaus & Co, 5000 Köln Orales Urolithiasismittel
DE3046580A1 (de) * 1980-12-11 1982-07-01 Leskovar, Peter, Dr.-Ing., 8000 München Harnsteinaufloesende mittel
DE3728814A1 (de) * 1987-08-28 1989-03-30 Lentia Gmbh Loesung zur anwendung als spuelfluessigkeit in der zerstoerung von koerperfremden ablagerungen in menschlichen und tierischen geweben oder koerperhohlraeumen
JP2545479B2 (ja) * 1989-02-07 1996-10-16 ミッション ファーマカル カンパニー,インコーポレーテッド 医薬組成物
CA1326040C (en) * 1989-11-16 1994-01-11 Neill B. Walsdorf Magnesium-potassium citrate
DE4409949C2 (de) * 1994-03-23 1996-11-21 Madaus Ag Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes
DE10028167B4 (de) * 2000-06-09 2004-02-19 Storch, Rüdiger, Dr. Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen
WO2009143021A1 (en) * 2008-05-22 2009-11-26 Bristol-Myers Squibb Company Method for treating and preventing kidney stones employing an sglt2 inhibitor and composition containing same
FR2967576B1 (fr) * 2010-11-18 2013-07-12 Advicenne Pharma Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament
FR2967578B1 (fr) 2010-11-18 2012-12-28 Advicenne Pharma Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
WO2014152789A1 (en) * 2013-03-15 2014-09-25 New York University Citrate containing beverage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
FR2019261A1 (en) * 1969-03-19 1970-07-03 Melon Jean Marie Treatment of oxalic lithiase with succinic - acid and its derivs

Also Published As

Publication number Publication date
CA978479A (en) 1975-11-25
IL40685A0 (en) 1972-12-29
CS217603B1 (en) 1983-01-28
DE2252665C2 (en:Method) 1987-09-10
AT332531B (de) 1976-10-11
SU1009467A1 (ru) 1983-04-07
DE2252665A1 (de) 1973-05-10
HU165181B (en:Method) 1974-07-27
IL40685A (en) 1976-08-31
GB1403900A (en) 1975-08-28
ATA925372A (de) 1976-01-15

Similar Documents

Publication Publication Date Title
CS157213B1 (en:Method)
DK136818C (en:Method)
HU165181B (en:Method)
CS170198B2 (en:Method)
DK142303C (en:Method)
DK135773C (en:Method)
FI49646B (en:Method)
CS165365B2 (en:Method)
FI53349B (en:Method)
DE7104173U (en:Method)
DE2139432B2 (en:Method)
CS177464B1 (en:Method)
AU3005371A (en:Method)
FR2122313A1 (en:Method)
FR2090832A5 (en:Method)
FR2119781A5 (en:Method)
FR2104503A5 (en:Method)
CS152218B1 (en:Method)
DE2134613A1 (en:Method)
DE2148659A1 (en:Method)
CS160991B1 (en:Method)
CS166948B1 (en:Method)
CS151187B1 (en:Method)
CS151150B1 (en:Method)
CS149202B1 (en:Method)